CPIX vs MA · rev $10.4M vs P/E 38, rev $32.79B
Cumberland Pharmaceuticals Inc (CPIX) versus Mastercard Inc (MA) — a side-by-side from cached financials, not a winner call.
Cumberland Pharmaceuticals Inc (CPIX) is a drug manufacturers - specialty & generic company listed on US.
Mastercard Inc (MA) is a credit services company listed on US. It is led by Michael Miebach.
Latest reported CPIX revenue for 2024-12-31 was $10.4M. Net income was -$1.9M. Revenue was up 14.9% from 2024-09-30 to 2024-12-31. CPIX currently screens at market cap $86.9M.
Latest reported MA revenue for 2025-12-31 was $32.79B. Net income was $14.97B. Revenue was up 16.4% from 2024-12-31 to 2025-12-31. MA currently screens at market cap $515.12B and trailing P/E 38.4.
CPIX currently screens at market cap $86.9M. MA currently screens at market cap $515.12B and trailing P/E 38.4.
Not investment advice. Open the CPIX and MA stock pages for the full models.
Not investment advice.